Prognostic importance of pretreatment and on-treatment blood pressure: Further analysis of the ACTION database and the effect of nifedipine gastrointestinal therapeutic system

Blood Pressure
Henry L ElliottPeter A Meredith

Abstract

This retrospective further analysis of the ACTION database evaluated the relationships between baseline blood pressure (BP), on-treatment BP (after 6 weeks) and subsequent cardiovascular outcomes. Analyses were performed using multivariate Cox proportional hazard models. Statistically significant (p < 0.001) and consistent patterns were noted between the risk of major cardiovascular endpoints and both baseline SBP and on-treatment SBP. The lowest risk of debilitating stroke was apparent in those patients with baseline SBP < 120mmHg, with a hazard ratio in this lowest BP group of 0.45 (95% confidence interval 0.28, 0.72), compared to the referent highest BP group (SBP < 150mmHg). Adjusting the model for treatment (nifedipine or placebo) did not modify the conclusions in any statistical or clinically meaningful way. Corresponding and similar results were obtained for pulse pressure but diastolic blood pressure (DBP) was not a consistently useful predictor of outcome. These data confirm the predictive importance of on-treatment SBP (but not DBP) and contribute to the debate about treatment-related BP targets. In this analysis, treatment with nifedipine gastrointestinal therapeutic system in high-risk patients with coronary artery ...Continue Reading

References

Mar 1, 1992·Archives of Internal Medicine·L W McCloskeyG N Aagaard
Aug 18, 1989·JAMA : the Journal of the American Medical Association·M H AldermanH Cohen
Mar 14, 1987·Lancet·J M CruickshankF J Zacharias
Nov 1, 1986·British Medical Journal·J Coope, T S Warrender
Sep 8, 2004·Lancet·Philip A Poole-WilsonUNKNOWN Coronary disease Trial Investigating Outcome with Nifedipine gastrointestinal therapeutic system investigators
Feb 18, 2005·Journal of Hypertension·Jacobus LubsenUNKNOWN ACTION (A Coronary disease Trial Investigating Outcome with Nifedipine GITS) investigators
Sep 26, 2007·Archives of Internal Medicine·Robert H FagardYair Yodfat
May 16, 2008·BMJ : British Medical Journal·UNKNOWN Blood Pressure Lowering Treatment Trialists' CollaborationS MacMahon
Dec 5, 2008·The New England Journal of Medicine·Kenneth JamersonUNKNOWN ACCOMPLISH Trial Investigators
Mar 17, 2010·The New England Journal of Medicine·William C CushmanFaramarz Ismail-Beigi
May 27, 2010·European Heart Journal·Hiddo J Lambers HeerspinkUNKNOWN ADVANCE Collaborative Group
Sep 18, 2010·European Heart Journal·Sripal BangaloreUNKNOWN Treating to New Targets Steering Committee and Investigators

❮ Previous
Next ❯

Citations

Feb 14, 2016·Blood Pressure·Henry L ElliottThomas Hedner

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.